[
  {
    "ts": null,
    "headline": "Could Buying AbbVie Today Set You Up for Life?",
    "summary": "Don't bet against it.",
    "url": "https://finnhub.io/api/news?id=7d684b22da8d58c687b1879bf2fb5286777874d331cecb8ca0df087b53cde363",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764858900,
      "headline": "Could Buying AbbVie Today Set You Up for Life?",
      "id": 137680064,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Don't bet against it.",
      "url": "https://finnhub.io/api/news?id=7d684b22da8d58c687b1879bf2fb5286777874d331cecb8ca0df087b53cde363"
    }
  },
  {
    "ts": null,
    "headline": "BeOne Medicines Continues To Execute In Q3",
    "summary": "BeOne Medicines AG is rated Strong Buy as Brukinsa and Tevimbra drive robust growth and pipeline catalysts approach. Learn more about ONC stock here.",
    "url": "https://finnhub.io/api/news?id=680e6c50ae97373b9c6ccdfdafa63487da947558eb2a3b7917c10edc528d7a50",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764853891,
      "headline": "BeOne Medicines Continues To Execute In Q3",
      "id": 137686998,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1404912459/image_1404912459.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "BeOne Medicines AG is rated Strong Buy as Brukinsa and Tevimbra drive robust growth and pipeline catalysts approach. Learn more about ONC stock here.",
      "url": "https://finnhub.io/api/news?id=680e6c50ae97373b9c6ccdfdafa63487da947558eb2a3b7917c10edc528d7a50"
    }
  },
  {
    "ts": null,
    "headline": "How Strong Is AbbVie's Immunology Franchise After Humira's LOE?",
    "summary": "ABBV rebounds after Humira's LOE as soaring Skyrizi and Rinvoq sales drive a powerful immunology comeback.",
    "url": "https://finnhub.io/api/news?id=caea34f828e26f2cabbc48ededde901edc14c961bdd7f8dbb5d646d827c55ebe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764851940,
      "headline": "How Strong Is AbbVie's Immunology Franchise After Humira's LOE?",
      "id": 137680030,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "ABBV rebounds after Humira's LOE as soaring Skyrizi and Rinvoq sales drive a powerful immunology comeback.",
      "url": "https://finnhub.io/api/news?id=caea34f828e26f2cabbc48ededde901edc14c961bdd7f8dbb5d646d827c55ebe"
    }
  }
]